Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Medipharm Labs Corp (TSX: LABS ) 0.0650 UNCHANGED Streaming Delayed Price Updated: 3:33 PM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Medipharm Labs Corp MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY August 14, 2024 Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an... Via Benzinga Topics Cannabis Exposures Cannabis This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now August 09, 2024 Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,... Via Benzinga Topics Cannabis Exposures Cannabis Executive Changes In Cannabis Industry You Should Know About, New Appointments & More July 03, 2024 Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as... Via Benzinga Topics Cannabis Exposures Cannabis Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method June 20, 2024 Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to... Via Benzinga Topics Cannabis Exposures Cannabis Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position' May 15, 2024 Via Benzinga This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses March 27, 2024 Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,... Via Benzinga Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil February 07, 2024 Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products... Via Benzinga Topics Cannabis Exposures Cannabis Product Safety Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 December 22, 2023 This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and... Via Benzinga Topics Cannabis Exposures Cannabis MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report November 14, 2023 MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of... Via Benzinga MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M October 02, 2023 MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dis Via Benzinga MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next September 20, 2023 MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C. Via Benzinga MediPharm Labs Sees 16.5% QoQ Increase In International Medical Cannabis Sales, Announces New CEO November 15, 2021 CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS... Via Benzinga Topics Cannabis Exposures Cannabis MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director October 21, 2021 MediPharm Labs Corp. (TSX:LABS) (OTCQX: Via Benzinga MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia August 31, 2021 MediPharm Labs Corp. (TSX:LABS) (OTCQX: Via Benzinga MediPharm Labs Reports 24% QoQ Pop In International Sales, Q2 2021 Revenue Drops 63.6% YoY August 16, 2021 MediPharm Labs Corp. (TSX:LABS) (OTCQX: Via Benzinga MediPharm Labs Receives Canadian GMP Pharmaceutical Drug Establishment License July 14, 2021 Pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQX... Via Benzinga MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma June 08, 2021 MediPharm Labs Corp. (TSX:LABS) (OTCQX: Via Benzinga Topics Cannabis Exposures Cannabis MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know May 17, 2021 MediPharm Labs Corp. (TSX:LABS) (OTCQX: Via Benzinga Topics Cannabis Exposures Cannabis Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.